Citadel Advisors’s IM Cannabis IMCC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.53K Buy
+1,689
New +$13.9K ﹤0.01% 13513
2025
Q3
Sell
-408
Closed -$30.4K 13394
2025
Q2
$30.4K Buy
+408
New +$25.6K ﹤0.01% 11972
2024
Q4
Sell
-466
Closed -$33.4K 14910
2024
Q3
$33.4K Buy
466
+105
+29% +$8.04K ﹤0.01% 12330
2024
Q2
$29.9K Buy
+361
New +$41.5K ﹤0.01% 12276
2023
Q4
Sell
-128
Closed -$15.8K 14749
2023
Q3
$15.8K Buy
128
+33
+35% +$4.96K ﹤0.01% 12806
2023
Q2
$15.5K Buy
+95
New +$14.8K ﹤0.01% 12942
2022
Q3
Sell
-9
Closed -$11K 13073
2022
Q2
$11K Buy
9
+2
+29% +$4.31K ﹤0.01% 12564
2022
Q1
$28K Hold
7
﹤0.01% 13130
2021
Q4
$40K Buy
+7
New +$41K ﹤0.01% 13367

Other funds holding IMCC

Citadel Advisors's IMCC Position: Q2 2026 in Review

Citadel Advisors opened a new position in IM Cannabis (IMCC) in Q2 2026: 1,689 shares worth $8.53K. The stake represents ﹤0.01% of the portfolio and ranks #13513 among its holdings. This is a return to the name: Citadel Advisors previously reported a position in IMCC as recently as Q2 2025.

Citadel Advisors first reported a position in IMCC in Q4 2021 and has held it in 9 quarters since. The position peaked at $40K in Q4 2021. 10 funds tracked by Wall St. Rank hold IMCC as of Q2 2026.

  • Citadel Advisors held 1,689 shares of IM Cannabis worth $8.53K as of Q2 2026.
  • IM Cannabis was a new Citadel Advisors position in Q2 2026.
  • IM Cannabis made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #13513 holding.
  • Citadel Advisors first reported a position in IM Cannabis in Q4 2021 and has held it in 9 quarters since.
  • Citadel Advisors's IM Cannabis position peaked at $40K in Q4 2021.
  • 10 funds tracked by Wall St. Rank held IM Cannabis as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.